67 reports

‘Antibody-Mediated Rejection (AMR) – Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the AMR, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The AMR market report provides current...

  • Epidemiology
  • Monoclonal Antibody
  • Transplantation
  • United States
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • Drug Approval

“Etanercept - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Cutaneous Lupus Erythematosus in 7 Major Markets. A detailed picture of the Etanercept in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan,...

  • Monoclonal Antibody
  • Europe
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • United States
  • Health Expenditure

Report Scope The current report provides detailed exposure of media, sera and reagents used in cell culture.This report highlights the current and future market potential of culture media, sera and reagents used in cell culture along with a detailed analysis of the competitive environment, regulatory scenario, and technological...

  • Cell Therapy
  • World
  • Europe
  • North America
  • APAC
  • China
  • Japan
  • Middle East
  • United States
  • Mexico
  • United Kingdom
  • Canada
  • France
  • Germany
  • India

‘Gene and Cell Therapies targeting CNS Disorders – Market Insights and Market Forecast – 2026’ report delivers an in-depth understanding of the market trends of Gene and Cell Therapies targeting CNS Disorders in in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Gene and Cell Therapies targeting...

  • Cell Therapy
  • Mental Health
  • World
  • Spain
  • France
  • Germany
  • United States
  • Italy
  • United Kingdom
  • Health Expenditure

‘B-cell Non-Hodgkin’s Lymphoma—Market Insights, Epidemiology, and Market Forecast—2028’ report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of B-cell NHL in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. Geography...

  • Immunotherapy
  • Lymphoma
  • Spain
  • Germany
  • France
  • Japan
  • United States
  • Italy
  • United Kingdom
  • Stem Cell Transplantation

‘Adeno-Associated Virus (AAV) Vector Based Gene Therapy - Market Insights, Epidemiology and Market Forecast—2030’ report delivers an in-depth understanding of the AAV Vector Based Gene Therapy, historical and forecasted epidemiology as well as the AAV Vector Based Gene Therapy market trends in the United States, EU5 (Germany, France, Italy,...

  • Gene Therapy
  • United States
  • Germany
  • Spain
  • France
  • Japan
  • Italy
  • United Kingdom
  • Medical Technology Density
  • Hospital Admission

Benitec Biopharma Ltd

  • Gene Therapy
  • Healthcare
  • Pharmaceutical
  • California
  • Baden-Württemberg
  • Prescription Drug Sales
  • Health Provider Density

Evaluation of Therapeutic Segments Including Monoclonal Antibodies, Insulin, Fusion Proteins, Interferons and Gene Therapies; Prediction of Leading National Markets (US, Japan, EU5 and BRIC); Investigation of Top Products Including Humira, Remicade, Lantus and Enbrel; and Assessment of R&D Including Sirukumab and NurOwn Report...

  • Biopharmaceutical
  • Pharmaceutical
  • Regenerative Medicine
  • Gene Therapy
  • Monoclonal Antibody
  • Japan
  • United States
  • BRIC
  • Spain
  • China
  • France
  • Germany
  • Russia
  • India
  • Italy
  • Brazil
  • United Kingdom

Array BioPharma Inc

  • Pharmaceutical
  • Biopharmaceutical
  • Healthcare
  • Monoclonal Antibody
  • Clinical Trial
  • Bavaria
  • Sweden
  • Greenhouse Gas Emissions
  • Prescription Drug Sales

Hemispherx Biopharma, Inc. said it is expanding its partnership with myTomorrows to supply Ampligen for pancreatic cancer patients in Canada under a Special Access Program (SAP).

  • Orthopedics
  • Clinical Trial
  • Gene Therapy
  • Clinical Research
  • Pancreatic Cancer
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Direct Sales
  • Manufacturing Orders

Hemispherx Biopharma, Inc. said it is expanding its partnership with myTomorrows to supply Ampligen for pancreatic cancer patients in Canada under a Special Access Program (SAP).

  • Hospital
  • Orthopedics
  • Clinical Trial
  • Gene Therapy
  • Pancreatic Cancer
  • Germany
  • Direct Sales
  • Medical Devices Sales

Hemispherx Biopharma, Inc. said it is expanding its partnership with myTomorrows to supply Ampligen for pancreatic cancer patients in Canada under a Special Access Program (SAP).

  • Orthopedics
  • Clinical Trial
  • Gene Therapy
  • Pancreatic Cancer
  • Germany
  • Direct Sales
  • Drug Approval

Can new biologics breathe fresh competition into the targeted asthma treatment landscape? The severe asthma treatment landscape is evolving. Near-term debates will focus on how best to use currently approved treatments, including Xolair, Nucala and Cinqair/Cinqaero, and which treatments offer the best for patients. Visible on the horizon...

  • Asthma
  • Respiratory Treatment
  • Monoclonal Antibody
  • Germany
  • Europe
  • United States
  • Occitanie

The report presents a detailed analysis of the Papillomavirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Papillomavirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market...

  • Diagnostics
  • Public Health
  • Monoclonal Antibody
  • Europe
  • Spain
  • France
  • Japan
  • Germany
  • United States
  • Italy
  • United Kingdom

The report presents a detailed analysis of the Pneumonia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Pneumonia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:

  • Infectious Disease
  • Diagnostics
  • Public Health
  • Monoclonal Antibody
  • Europe
  • Spain
  • France
  • Japan
  • Germany
  • United States
  • Italy
  • United Kingdom

MeiraGTx Limited, a company engaged in the development of novel gene therapy treatments, has acquired Kadmon Gene Therapy Holdings Limited, a company focused on gene therapy treatments, from Kadmon Corporation, LLC, a biopharmaceutical company.

  • Gene Therapy
  • Pharmaceutical
  • Clinical Trial
  • Healthcare
  • United Kingdom
  • England
  • Caddo Parish
  • Germany
  • Land Berlin
  • Working Age Population
  • Number Of R&D Personnel

Alerpharma wholly owns the Spanish-based allergy immunotherapy company Instituto de Immunologia y Alergia, S.A.U. (Inmunal), a spin-out from a biopharmaceutical company, Zeltia S.A.Alerpharma recorded unaudited turnover and pre-tax profits of approximately EUR##.## million (USD##.## million) and EUR##.## (USD##.## million) respectively in the financial year ended December ##, and its unaudited net assets as at December ## were approximately EUR##.## million (USD##.## million).

  • Allergy Immunotherapy
  • Pharmaceutical
  • Healthcare
  • United States
  • Germany
  • Europe
  • Spain
  • United Kingdom
  • Drug Approval

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • United States
  • Italy
  • United Kingdom

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom

The global human embryonic stem cells (hESCs) market is anticipated to reach USD 1.06 billion by 2025, according to a new report by Grand View Research, Inc. Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025. hESCs technology tends to be useful for tissue...

  • Regenerative Medicine
  • Cell Therapy
  • World
  • North America
  • China
  • Japan
  • Germany
  • United States
  • United Kingdom

Summary 4-Antibody AG (4-Antibody), a subsidiary of Agenus Inc is a biopharmaceutical company that develops antibody drug-discovery and optimization technology platform. The company discovers and develops therapeutic antibodies for the treatment of serious medical conditions such as oncology and autoimmunity, infectious diseases...

  • Biopharmaceutical
  • Pharmaceutical
  • Immunotherapy
  • APAC
  • Switzerland
  • Europe
  • North America
  • Germany
  • Middle East
  • Africa
  • Central America

Celltrion Inc (Celltrion) is a biopharmaceutical company that focuses on research, development and manufacture of biosimilars and novel biopharmaceuticals.

  • Immunotherapy
  • Private Placement
  • Research Center
  • Germany
  • Printed Circuit Board Production
  • Dates Price

“Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight” report by PNS Pharma gives comprehensive clinical insight on 37 biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar version of Lantus are commercially available in India, Japan, Kenya, Czech Republic, Estonia, Germany, China, Slovakia, United...

  • Recombinant Insulin
  • China
  • Japan
  • Estonia
  • Germany
  • Kenya
  • India
  • Czech Republic
  • Slovakia
  • United Kingdom

Summary MedGenesis Therapeutix Inc (MedGenesis) is a biopharmaceutical company that develops and commercializes therapeutics for treatment of serious neurological diseases. The company also offers treatments for other CNS conditions such as intractable epilepsy, brain cancer, sensorineural hearing loss and severely debilitating...

  • Pharmaceutical
  • Therapy
  • Biopharmaceutical
  • Psychotic Disorder
  • Neurological Disorder
  • North America
  • APAC
  • Canada
  • Europe
  • Germany
  • Middle East
  • United States
  • Africa
  • British Columbia

This report presents quick facts about Affimed N.V., which is principally a Clinical-Stage Biopharmaceutical Company. Illustrated with 53 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

  • Biopharmaceutical
  • Germany

Merck LAG-## Roche Pharmaceutical Monoclonal Antibody Cancer Immunotherapy Biopharmaceutical Therapy

  • Cancer Immunotherapy
  • Clinical Trial
  • Therapy
  • Monoclonal Antibody
  • France
  • G7
  • United States
  • Europe
  • North America
  • Germany
  • Italy
  • United Kingdom
  • Asia
  • Drug Approval